secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001801170-25-000154
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health stockholders elect directors, approve pay, ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Dr. Anna U. Loengard and William G. Robinson, Jr. elected as Class I directors for term expiring 2028.
- Non-binding say-on-pay proposal for 2024 executive compensation approved with over 988 million votes in favor.
- Ratification of Ernst & Young LLP as independent auditor for FY2025 received over 1.15 billion votes in favor.
- All proposals passed with substantial majority; broker non-votes on first two items totaled ~162 million.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117025000154/0001801170-25-000154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117025000154/clov-20250610.htm
  HTML page:      https://secwatch.observer/filing/0001801170-25-000154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer